All sites C00-96,D32-33,D42-43,D45-47,D76 639 90.2 2.6 2.2 1.1 3.9
Mouth, pharynx C00-14 13 95.4 4.6 - - -
  Lip C00 3 100.0 - - - -
  Tongue C02 1 100.0 - - - -
  Mouth, other C03-06 3 100.0 - - - -
  Salivary glands C07-08 2 66.7 33.3 - - -
  Pharynx C01,C09-14 4 100.0 - - - -
Digestive organs C15-26 126 90.1 1.0 3.2 1.9 3.8
  Oesophagus C15 8 89.5 - - 2.6 7.9
  Stomach C16 16 96.2 - - 1.3 2.5
  Small intestine C17 2 83.3 - - 8.3 8.3
  Colon C18 37 98.4 - - - 1.6
  Rectum, rectosigmoid C19-20 27 98.5 - - 0.7 0.7
  Anus C21 1 100.0 - - - -
  Liver C22 12 86.9 - 8.2 4.9 -
  Gallbladder, bile ducts C23-24 4 68.4 5.3 5.3 10.5 10.5
  Pancreas C25 18 66.7 5.6 15.6 2.2 10.0
  Other digestive organs C26 2 50.0 - - 12.5 37.5
Respiratory organs C30-39 68 75.4 7.3 8.2 2.0 7.0
  Nose, sinuses C30-31 1 85.7 - - - 14.3
  Larynx, epiglottis C32 4 95.2 - - 4.8 -
  Lung, trachea C33-34 62 74.1 8.1 9.1 1.9 6.8
  Mediastinum, pleura C38 - - - - - -
Bone C40-41 1 100.0 - - - -
Melanoma of the skin C43 30 100.0 - - - -
Skin, non-melanoma C44 45 100.0 - - - -
Mesothelioma C45 2 100.0 - - - -
Autonomic nervous system C47 - - - - - -
Soft tissues C48-49 4 94.7 - - - 5.3
Breast C50 2 100.0 - - - -
Male genital organs C60-63 196 99.4 - 0.1 0.2 0.3
  Prostate C61 190 99.4 - 0.1 0.2 0.3
  Testis C62 5 100.0 - - - -
  Other male genital C60,C63 1 100.0 - - - -
Urinary organs C64-68 52 94.2 1.2 - 0.4 4.2
  Kidney C64 18 90.1 1.1 - - 8.8
  Bladder and urinary tract2 C65-68 34 96.4 1.2 - 0.6 1.8
Eye C69 1 60.0 - 40.0 - -
Brain, central nervous system C70-72,D32-33,D42-43 20 84.7 - 5.1 1.0 9.2
Thyroid gland C73 4 95.5 4.5 - - -
Other endocrine glands C74-75 0 100.0 - - - -
Illdefined or unknown C76,C80 15 63.5 1.4 16.2 2.7 16.2
Lymphoid and haematopoietic tissue C81-96,D45-47,D76 61 68.7 14.0 1.0 3.3 13.0
  Hodgkin lymphoma C81 3 100.0 - - - -
  Non-Hodgkin lymphoma C82-86,C96,D76 25 97.6 - - - 2.4
  Malignant immunoproliferative diseases C88 1 80.0 - - 20.0 -
  Myeloma and other plasma cell tumors C90 9 37.0 21.7 6.5 8.7 26.1
  Leukaemia C91-95 14 47.1 35.3 - 4.4 13.2
  Myelodysplastic syndromes D46 3 17.6 11.8 - 5.9 64.7
  Myeloproliferaitive neoplasms D45,D47 5 51.9 25.9 - 3.7 18.5
Not included above
  Basal cell carcinoma of the skin 58 100.0 - - - -
1 The following order of preference for confirmation of the diagnosis is used:
1. Histology (including autopsy, and bone marrow and blood smear examination in leukaemias)
2. Cytology
3. Surgery (including endoscopy), autopsy without histology, X-ray and some specified laboratory examinations
4. Clinical examination only
2 PUNLMP and ca in situ of the uroepithelium are included.